Key statistics
As of last trade Aldeyra Therapeutics Inc (ALDX:NAQ) traded at 5.36, -18.14% below its 52-week high of 6.55, set on Sep 05, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 5.34 |
---|---|
High | 5.48 |
Low | 5.23 |
Bid | 5.36 |
Offer | 5.38 |
Previous close | 5.34 |
Average volume | 528.91k |
---|---|
Shares outstanding | 59.42m |
Free float | 48.69m |
P/E (TTM) | -- |
Market cap | 317.31m USD |
EPS (TTM) | -0.6387 USD |
Data delayed at least 15 minutes, as of Oct 07 2024 17:16 BST.
More ▼
Press releases
- Aldeyra Therapeutics Resubmits Reproxalap New Drug Application for the Treatment of Dry Eye Disease
- Aldeyra Therapeutics to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
- Aldeyra Therapeutics Achieves Primary Endpoint in Phase 3 Dry Eye Disease Clinical Trial of Reproxalap
- Aldeyra Therapeutics Schedules Conference Call and Webcast to Announce Top-Line Results from the Phase 3 Dry Eye Chamber Clinical Trial of Reproxalap